US Stock MarketDetailed Quotes

AXGN AxoGen

Watchlist
  • 14.250
  • -0.460-3.13%
Close Oct 14 16:00 ET
624.57MMarket Cap-36538P/E (TTM)

About AxoGen Company

Axogen, Inc. engages in the development and market of surgical solutions for peripheral nerve regeneration and repair. It also provides products and education to improve surgical treatment algorithms for peripheral nerve damage or discontinuity. The firm’s products include avance nerve graft, axoguard nerve connector, axoguard nerve protector, avive soft tissue membrane, acroval neurosensory and motor testing system, and axotouch two-point discriminator. The company was founded in 1977 and is headquartered in Alachua, FL.

Company Profile

SymbolAXGN
Company NameAxoGen
Listing DateAug 9, 2013
Founded1977
CEOMr. Michael D. Dale
MarketNASDAQ
Employees428
Fiscal Year Ends12-31
Address13631 Progress Boulevard,Suite 400
CityAlachua
ProvinceFlorida
CountryUnited States of America
Zip Code32615
Phone1-386-462-6800

Company Executives

  • Name
  • Position
  • Salary
  • Michael D. Dale
  • Director, Chief Executive Officer and President
  • --
  • Nir Naor
  • Chief Financial Officer and Principal Accounting Officer
  • 60.29K
  • Erick Wayne DeVinney
  • Vice President, Peripheral Nerve Science
  • 1.51M
  • Todd Puckett
  • Vice President, Manufacturing
  • --
  • Paul G. Thomas
  • Chairman of the Board
  • 220.00K
  • William P. Burke
  • Independent Director
  • 220.00K
  • John H. Johnson
  • Independent Director
  • 215.00K
  • Amy A. Wendell
  • Lead Independent Director
  • 255.00K
  • Guido J. Neels
  • Independent Director
  • 217.50K
  • Dr. Joseph Adrian Tyndall, M.D.,M.P.H.
  • Independent Director
  • 205.00K
  • Kathy Johnson Weiler
  • Independent Director
  • 293.37K
  • Alan M. Levine
  • Independent Director
  • 217.50K

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data